Oncode Institute
Thijn Brummelkamp is a Professor of Experimental Genetics at Universitair Medisch Centrum Utrecht and the Co-Founder of Scenic Biotech. Thijn is also a Group leader at Oncode Institute, The Netherlands Cancer Institute, and Haplogen. With a PhD in Cancer Research from Netherands Cancer Institute/Utrecht University and a Master of Science (MSc) in Biology from Free University, Amsterdam, Thijn Brummelkamp has a wealth of experience in the field. Additionally, Thijn has served as an Adjunct Principal Investigator at CeMM and as a Whitehead Fellow at Whitehead Institute.
This person is not in any teams
Oncode Institute
Oncode Institute is an independent institute dedicated to understanding cancer and translating research into practice. Oncode, starting from a deeper understanding of the basics of cancer, works to come up with better treatments and improved diagnostics. Our goal: helping more patients survive, improving the quality of life for those afflicted, and ultimately curing cancer. The complexity of cancer calls for strategic action and collaboration. Instead of new buildings, we are constructing a network, in which experienced, leading scientists and gifted young researchers at partner institutions strive together toward a greater, common goal, supported by KWF Kankerbestrijding and the Dutch Government. Because only by working together we can outsmart cancer. Official launch on February 5th, 2018 If you have any questions or suggestions, please feel free to contact us at anytime. info@oncode.nl